Week In Review: I-Mab Files For Hong Kong SPAC IPO To Acquire Life Science Company
April 30, 2022 at 14:45 PM EDT
I-Mab and one of its investors, VMS, have filed for a Hong Kong IPO of a SPAC that will raise funds to acquire a life science company. Also, RVAC Medicines completed a Series B funding that brings total funds raised since inception to $140 million.
